Paxlovid™ reduces the incidence of pneumonia, hospitalization, and death in a cohort of COVID-19 patients from northeast Mexico

• Egile Nagusiak: María Elena Camacho Moll (Egilea), Ana Maria Salinas Martínez (Egilea), Minna Wu (Egilea), Gloria Navarrete Floriano (Egilea), Juan Carlos Romo Salazar (Egilea), Jorge Eleazar Cruz Luna (Egilea), Mario Bermúdez de León (Egilea)
• Formatua: Liburua
• Argitaratua: Elsevier, 2024-07-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Background: Information on Paxlovid™ effectiveness must be monitored and updated in real world scenarios. Our research question was what is the effectiveness of Paxlovid™ in adult patients with COVID-19? Therefore, we investigated the effectiveness of Paxlovid™ on reducing the incidence of pneumonia...